D5.1 Development of algorithms using artificial intelligence to characterize performance in clinical decision-making

This platform will be based on the data collected by the platform developed under PSS3 (documentation of health evidence), which can be used internationally in clinical trials and economic analyses. By focusing on a large volume of real data, the analyses to be carried out will have greater explanatory power. In addition, the data can be used to train human resources in the field of health, who will now have agile and transparent access to data and results that are relevant to patients and other stakeholders, and to measure and manage health costs.

Date Start

Nov. 2, 2021

Date End

Oct. 31, 2024